Annual Interest Expense
$3.09 B
+$882.00 M+39.93%
December 1, 2024
Summary
- As of February 7, 2025, PFE annual interest expense is $3.09 billion, with the most recent change of +$882.00 million (+39.93%) on December 1, 2024.
- During the last 3 years, PFE annual interest expense has risen by +$1.80 billion (+139.43%).
- PFE annual interest expense is now at all-time high.
Performance
PFE Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$739.00 M
-$44.00 M-5.62%
December 1, 2024
Summary
- As of February 7, 2025, PFE quarterly interest expense is $739.00 million, with the most recent change of -$44.00 million (-5.62%) on December 1, 2024.
- Over the past year, PFE quarterly interest expense has dropped by -$51.00 million (-6.46%).
- PFE quarterly interest expense is now -6.46% below its all-time high of $790.00 million, reached on March 31, 2024.
Performance
PFE Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$3.09 B
+$51.00 M+1.68%
December 1, 2024
Summary
- As of February 7, 2025, PFE TTM interest expense is $3.09 billion, with the most recent change of +$51.00 million (+1.68%) on December 1, 2024.
- Over the past year, PFE TTM interest expense has increased by +$409.00 million (+15.26%).
- PFE TTM interest expense is now at all-time high.
Performance
PFE TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
PFE Interest Expense Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +39.9% | -6.5% | +15.3% |
3 y3 years | +139.4% | +137.6% | +148.8% |
5 y5 years | +96.5% | +89.5% | +92.8% |
PFE Interest Expense Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +149.7% | -6.5% | +152.2% | at high | +150.2% |
5 y | 5-year | at high | +149.7% | -6.5% | +152.2% | at high | +150.2% |
alltime | all time | at high | +499.0% | -6.5% | +165.8% | at high | +737.4% |
Pfizer Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $3.09 B(+39.9%) | $739.00 M(-5.6%) | $3.09 B(+1.7%) |
Sep 2024 | - | $783.00 M(+0.6%) | $3.04 B(+3.0%) |
Jun 2024 | - | $778.00 M(-1.5%) | $2.95 B(+10.1%) |
Mar 2024 | - | $790.00 M(+14.8%) | $2.68 B(+21.4%) |
Dec 2023 | $2.21 B(+78.4%) | $688.00 M(-1.0%) | $2.21 B(+20.4%) |
Sep 2023 | - | $695.00 M(+36.8%) | $1.83 B(+26.5%) |
Jun 2023 | - | $508.00 M(+59.7%) | $1.45 B(+17.4%) |
Mar 2023 | - | $318.00 M(+1.6%) | $1.24 B(-0.3%) |
Dec 2022 | $1.24 B(-4.1%) | $313.00 M(+0.6%) | $1.24 B(-0.2%) |
Sep 2022 | - | $311.00 M(+6.1%) | $1.24 B(-1.1%) |
Jun 2022 | - | $293.00 M(-9.0%) | $1.26 B(-1.8%) |
Mar 2022 | - | $322.00 M(+1.9%) | $1.28 B(-1.1%) |
Dec 2021 | $1.29 B(-10.9%) | $316.00 M(-2.8%) | $1.29 B(-2.3%) |
Sep 2021 | - | $325.00 M(+2.8%) | $1.32 B(-1.5%) |
Jun 2021 | - | $316.00 M(-6.0%) | $1.34 B(-3.7%) |
Mar 2021 | - | $336.00 M(-3.2%) | $1.40 B(-3.7%) |
Dec 2020 | $1.45 B(-7.9%) | $347.00 M(+0.6%) | $1.45 B(-4.5%) |
Sep 2020 | - | $345.00 M(-6.0%) | $1.52 B(-4.0%) |
Jun 2020 | - | $367.00 M(-5.9%) | $1.58 B(-1.4%) |
Mar 2020 | - | $390.00 M(-6.0%) | $1.60 B(+1.8%) |
Dec 2019 | $1.57 B(+19.5%) | $415.00 M(+1.5%) | $1.57 B(+2.9%) |
Sep 2019 | - | $409.00 M(+5.1%) | $1.53 B(+6.9%) |
Jun 2019 | - | $389.00 M(+7.8%) | $1.43 B(+4.6%) |
Mar 2019 | - | $361.00 M(-2.4%) | $1.37 B(+3.9%) |
Dec 2018 | $1.32 B(+3.6%) | $370.00 M(+19.4%) | $1.32 B(+3.1%) |
Sep 2018 | - | $310.00 M(-4.9%) | $1.28 B(-0.8%) |
Jun 2018 | - | $326.00 M(+5.2%) | $1.29 B(+1.1%) |
Mar 2018 | - | $310.00 M(-6.1%) | $1.27 B(+0.1%) |
Dec 2017 | $1.27 B | $330.00 M(+3.1%) | $1.27 B(+2.7%) |
Sep 2017 | - | $320.00 M(+2.6%) | $1.24 B(+2.4%) |
Jun 2017 | - | $312.00 M(+1.0%) | $1.21 B(+1.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2017 | - | $309.00 M(+4.0%) | $1.19 B(+0.3%) |
Dec 2016 | $1.19 B(-1.1%) | $297.00 M(+2.1%) | $1.19 B(-3.1%) |
Sep 2016 | - | $291.00 M(-0.3%) | $1.22 B(+1.1%) |
Jun 2016 | - | $292.00 M(-4.6%) | $1.21 B(+1.2%) |
Mar 2016 | - | $306.00 M(-8.7%) | $1.20 B(-0.3%) |
Dec 2015 | $1.20 B(-11.8%) | $335.00 M(+20.5%) | $1.20 B(-1.5%) |
Sep 2015 | - | $278.00 M(0.0%) | $1.22 B(-5.1%) |
Jun 2015 | - | $278.00 M(-10.0%) | $1.28 B(-4.8%) |
Mar 2015 | - | $309.00 M(-12.5%) | $1.35 B(-0.9%) |
Dec 2014 | $1.36 B(-3.8%) | $353.00 M(+2.9%) | $1.36 B(+0.4%) |
Sep 2014 | - | $343.00 M(0.0%) | $1.35 B(+0.2%) |
Jun 2014 | - | $343.00 M(+6.9%) | $1.35 B(-1.0%) |
Mar 2014 | - | $321.00 M(-7.5%) | $1.36 B(-3.5%) |
Dec 2013 | $1.41 B(-7.1%) | $347.00 M(+2.1%) | $1.41 B(-1.8%) |
Sep 2013 | - | $340.00 M(-4.5%) | $1.44 B(-2.8%) |
Jun 2013 | - | $356.00 M(-4.0%) | $1.48 B(-1.5%) |
Mar 2013 | - | $371.00 M(-0.5%) | $1.50 B(-1.2%) |
Dec 2012 | $1.52 B(-9.5%) | $373.00 M(-2.1%) | $1.52 B(-1.5%) |
Sep 2012 | - | $381.00 M(+0.8%) | $1.54 B(-2.6%) |
Jun 2012 | - | $378.00 M(-3.1%) | $1.59 B(+6.1%) |
Mar 2012 | - | $390.00 M(-1.5%) | $1.50 B(-4.3%) |
Dec 2011 | $1.68 B(-6.5%) | $396.00 M(-6.4%) | $1.56 B(-3.9%) |
Sep 2011 | - | $423.00 M(+47.4%) | $1.63 B(-0.2%) |
Jun 2011 | - | $287.00 M(-37.3%) | $1.63 B(-5.9%) |
Mar 2011 | - | $458.00 M(-0.2%) | $1.73 B(-3.6%) |
Dec 2010 | $1.80 B(+45.7%) | $459.00 M(+7.5%) | $1.80 B(-0.3%) |
Sep 2010 | - | $427.00 M(+9.8%) | $1.80 B(+3.3%) |
Jun 2010 | - | $389.00 M(-25.5%) | $1.74 B(+28.7%) |
Mar 2010 | - | $522.00 M(+12.5%) | $1.35 B(+62.7%) |
Dec 2009 | $1.23 B(+139.0%) | $464.00 M(+25.7%) | $833.00 M(+125.7%) |
Sep 2009 | - | $369.00 M | $369.00 M |
Dec 2008 | $516.00 M | - | - |
FAQ
- What is Pfizer annual interest expense?
- What is the all time high annual interest expense for Pfizer?
- What is Pfizer annual interest expense year-on-year change?
- What is Pfizer quarterly interest expense?
- What is the all time high quarterly interest expense for Pfizer?
- What is Pfizer quarterly interest expense year-on-year change?
- What is Pfizer TTM interest expense?
- What is the all time high TTM interest expense for Pfizer?
- What is Pfizer TTM interest expense year-on-year change?
What is Pfizer annual interest expense?
The current annual interest expense of PFE is $3.09 B
What is the all time high annual interest expense for Pfizer?
Pfizer all-time high annual interest expense is $3.09 B
What is Pfizer annual interest expense year-on-year change?
Over the past year, PFE annual interest expense has changed by +$882.00 M (+39.93%)
What is Pfizer quarterly interest expense?
The current quarterly interest expense of PFE is $739.00 M
What is the all time high quarterly interest expense for Pfizer?
Pfizer all-time high quarterly interest expense is $790.00 M
What is Pfizer quarterly interest expense year-on-year change?
Over the past year, PFE quarterly interest expense has changed by -$51.00 M (-6.46%)
What is Pfizer TTM interest expense?
The current TTM interest expense of PFE is $3.09 B
What is the all time high TTM interest expense for Pfizer?
Pfizer all-time high TTM interest expense is $3.09 B
What is Pfizer TTM interest expense year-on-year change?
Over the past year, PFE TTM interest expense has changed by +$409.00 M (+15.26%)